TCT 914: Impact of Visual Estimation versus Quantitative Coronary Angiography of Diameter Stenosis on Clinical Outcomes in the LIFE-BTK Trial

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Consultant Fee/Honoraria/Speaker’s Bureau - Abbott; Biotronik</li><li>Grant Support/Research Contract - Abbott; Biotronik; Cordis Corporation, a Johnson & Johnson company; Philips</li></ul>